Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of Earliest Event Reported):
  
May 3, 2011
  
STAAR Surgical Company
(Exact name of registrant as specified in its charter)
 
Delaware
  
0-11634
  
95-3797439
(State or other jurisdiction
  
(Commission
  
(I.R.S. Employer
of incorporation)
  
File Number)
  
Identification No.)
  
        
1911 Walker Ave, Monrovia, California
      
91016
(Address of principal executive offices)
      
(Zip Code)

Registrant’s telephone number, including area code:
  
626-303-7902
 
Not Applicable
Former name or former address, if changed since last report
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

Item 2.02 Results of Operations and Financial Condition.
 
On May 3, 2011, STAAR Surgical Company (the “Company”) published a press release reporting its financial results for the quarter ended April 1, 2011, a copy of which is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.
 
Item 7.01 Regulation FD Disclosure.
 
On May 3, 2010, the Company held a conference call to discuss the financial results for the quarter ended April 1, 2011.  An archive of the webcast of the conference call has been posted on the Company’s website at www.staar.com. A transcript of the conference call is furnished as Exhibit 99.2 to this report and is incorporated herein by this reference.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
STAAR Surgical Company
  
       
May 6, 2011
By:
/s/ Barry G. Caldwell  
   
Barry G. Caldwell
  
   
President and Chief Executive Officer
  
       
 
 
Exhibit Index
 
Exhibit No.
Description
 
99.1 
Press release of the Company dated May 3, 2011.
 
99.2 
Conference call of the Company held on May 3, 2011.